ALAMAB THERAPEUTICS INC. — Form D
ALAMAB THERAPEUTICS INC. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-04. The offering totals $47.4M, of which $11.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-04
- Form: D
- Accession: 0001713896-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $47.4M
- Amount sold: $11.8M
- Remaining: $35.6M
- Investors: 1
- Date of first sale: 2017-07-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-292151
Issuer
- Name: ALAMAB THERAPEUTICS INC.
- CIK: 0001713896
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 302 CARNEGIE CENTER BLVD., PRINCETON, NJ, 08542
- Phone: 609-356-0210
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| JEAN X JIANG | Director | PRINCETON, NJ |
| JUMIN X SUN | Director | PRINCETON, NJ |
| Qingxi Wang | Director | Princeton, NJ |
| Qingxi Wang | Executive Officer | Princeton, NJ |
| YANFENG ZHANG | Executive Officer | PRINCETON, NJ |
More